Piper Sandler Maintains Overweight on Inspire Medical Systems, Raises Price Target to $360
Portfolio Pulse from Benzinga Newsdesk
Piper Sandler analyst Adam Mizrahi maintains an Overweight rating on Inspire Medical Systems (NYSE:INSP) and raises the price target from $335 to $360.
May 18, 2023 | 1:13 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Piper Sandler analyst maintains Overweight rating on Inspire Medical Systems (INSP) and raises price target from $335 to $360.
The news of Piper Sandler maintaining an Overweight rating and raising the price target for Inspire Medical Systems (INSP) from $335 to $360 indicates a positive outlook for the stock. This is likely to have a positive short-term impact on INSP's stock price as it shows increased confidence in the company's performance and potential growth.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100